Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Xeris Biopharma Holdings Insider Sold Shares Worth $255,828, According to a Recent SEC Filing

Xeris Biopharma Holdings Insider Sold Shares Worth $255,828, According to a Recent SEC Filing

MT newswireMT newswire2026/11/04 21:11
05:11 PM EST, 11/04/2026 (MT Newswires) -- Beth Hecht, Chief Legal Officer and Corporate Secretary, on November 02, 2026, sold 25,000 shares in Xeris Biopharma Holdings (XERS) for $255,828. Following the Form 4 filing with the SEC, Hecht has control over a total of 1,086,130 common shares of the company, with 1,086,130 shares held directly. Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867096/000186709626000109/xslF345X05/wk-form4_1793829477.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!